Robert CPA - Acasti Pharma Principal Officer
| ACST Stock | USD 2.76 0.06 2.22% |
Executive
Robert CPA is Principal Officer of Acasti Pharma
| Age | 52 |
| Address | 3009 boulevard de la Concorde East, Laval, QC, Canada, H7E 2B5 |
| Phone | 450-687-2262 |
| Web | https://www.acastipharma.com |
Acasti Pharma Management Efficiency
The company has return on total asset (ROA) of (0.0792) % which means that it has lost $0.0792 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4805) %, meaning that it created substantial loss on money invested by shareholders. Acasti Pharma's management efficiency ratios could be used to measure how well Acasti Pharma manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.25 in 2024, whereas Return On Tangible Assets are likely to drop (1.34) in 2024. Liabilities And Stockholders Equity is likely to gain to about 95.5 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 3.7 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| MD III | Akari Therapeutics PLC | 71 | |
| ScD MD | Moleculin Biotech | 72 | |
| Wendy CPA | Akari Therapeutics PLC | 57 | |
| MD FACP | Moleculin Biotech | 72 | |
| Dr MBA | Tonix Pharmaceuticals Holding | 66 | |
| John JD | Ocugen Inc | N/A | |
| Dolly Tyan | Aditxt Inc | N/A | |
| Carol MBA | Jaguar Animal Health | 60 | |
| Gregory MD | Tonix Pharmaceuticals Holding | 58 | |
| Michael MBA | Ocugen Inc | N/A | |
| Thomas OBrien | GeoVax Labs | N/A | |
| Sina Bavari | Tonix Pharmaceuticals Holding | N/A | |
| Uttam Patil | ABVC Biopharma | 38 | |
| Jyothy MS | Ocugen Inc | N/A | |
| John Sharkey | GeoVax Labs | 68 | |
| Peter Hodge | Jaguar Animal Health | N/A | |
| Felipe Duran | Ibio Inc | 44 | |
| MPH MD | Tonix Pharmaceuticals Holding | N/A | |
| MBA Ashizawa | Bio Path Holdings | N/A | |
| Arun Upadhyay | Ocugen Inc | 41 | |
| CMI MD | Ocugen Inc | N/A | |
Management Performance
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.0792 |
Acasti Pharma Leadership Team
Elected by the shareholders, the Acasti Pharma's board of directors comprises two types of representatives: Acasti Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acasti. The board's role is to monitor Acasti Pharma's management team and ensure that shareholders' interests are well served. Acasti Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acasti Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| George Kottayil, Chief US | ||
| Robert CPA, Principal Officer | ||
| Prashant Kohli, Chief Officer | ||
| Amresh Kumar, VP Management | ||
| Janelle DAlvise, President CEO | ||
| Yves Lachance, VP Compliance | ||
| Carrie DAndrea, VP Operations | ||
| Pierre MD, COO CoFounder | ||
| Christine Pelletier, Director HR |
Acasti Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Acasti Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.0792 | ||||
| Current Valuation | 288.39 K | ||||
| Shares Outstanding | 9.4 M | ||||
| Shares Owned By Insiders | 16.02 % | ||||
| Shares Owned By Institutions | 12.16 % | ||||
| Number Of Shares Shorted | 1.14 K | ||||
| Price To Earning | 15.34 X | ||||
| Price To Book | 0.49 X | ||||
| Price To Sales | 208.39 X |
Pair Trading with Acasti Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acasti Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Acasti Stock
| 0.75 | EQ | Equillium Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Acasti Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acasti Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acasti Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acasti Pharma to buy it.
The correlation of Acasti Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acasti Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acasti Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acasti Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acasti Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For more information on how to buy Acasti Stock please use our How to Invest in Acasti Pharma guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Acasti Stock analysis
When running Acasti Pharma's price analysis, check to measure Acasti Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acasti Pharma is operating at the current time. Most of Acasti Pharma's value examination focuses on studying past and present price action to predict the probability of Acasti Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acasti Pharma's price. Additionally, you may evaluate how the addition of Acasti Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Acasti Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acasti Pharma. If investors know Acasti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acasti Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.68) | Revenue Per Share 0.005 | Return On Assets (0.08) | Return On Equity (0.48) |
The market value of Acasti Pharma is measured differently than its book value, which is the value of Acasti that is recorded on the company's balance sheet. Investors also form their own opinion of Acasti Pharma's value that differs from its market value or its book value, called intrinsic value, which is Acasti Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acasti Pharma's market value can be influenced by many factors that don't directly affect Acasti Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acasti Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acasti Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acasti Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.